+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Adverum Biotechnologies - logo

Adverum is a gene therapy company that innovate and produce medicines for rare and eye diseases that do not have many existing treatments. Adverum focuses on 7 key areas such as: wAMD, A1T Deficiency, HAE, FA, Severe allergy, Color vision deficiency, and XLRS. Adverum biotechnologies was founded in 2006, and it is headquartered in Menlo park, California. The company was previously known as Avalanche Technologies but changed its name to Adverum Biotechnologies in May 2016. It has collaboration agreements with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize gene therapy products for ophthalmic diseases; and Editas Medicine, Inc. to explore the delivery of genome editing medicines for the treatment of inherited retinal diseases.

Diabetic Retinopathy - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
From
Vascular Endothelial Growth Factor Inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular Endothelial Growth Factor Inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Vascular endothelial growth factor A inhibitors - Pipeline Insight, 2024 - Product Thumbnail Image

Vascular endothelial growth factor A inhibitors - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
From
Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024 - Product Thumbnail Image

Wet Age-Related Macular Degeneration (Wet AMD) - Pipeline Insight, 2024

  • Clinical Trials
  • August 2024
  • 240 Pages
  • Global
From
From
From
Macular Degeneration Treatment Global Market Report 2024 - Product Thumbnail Image

Macular Degeneration Treatment Global Market Report 2024

  • Report
  • February 2024
  • 200 Pages
  • Global
From
Diabetic Macular Edema - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 180 Pages
  • Global
From
Wet Macular Degeneration - Pipeline Insight, 2024 - Product Thumbnail Image

Wet Macular Degeneration - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Hereditary Angioedema Therapeutics Market 2023-2027 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Market 2023-2027

  • Report
  • July 2023
  • 156 Pages
  • Global
From
From
Hereditary Angioedema Therapeutics Global Market Report 2024 - Product Thumbnail Image

Hereditary Angioedema Therapeutics Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
From
Loading Indicator